The global Drugs to Treat Chronic Kidney Disease market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for Drugs to Treat Chronic Kidney Disease is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Drugs to Treat Chronic Kidney Disease is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Drugs to Treat Chronic Kidney Disease in Hospital Pharmacies is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Drugs to Treat Chronic Kidney Disease include Pfizer Inc., Johnson & Johnson, AbbVie Inc., Bayer AG, Novartis AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca plc and Eli Lilly and Company, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Drugs to Treat Chronic Kidney Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs to Treat Chronic Kidney Disease.

Report Scope

The Drugs to Treat Chronic Kidney Disease market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drugs to Treat Chronic Kidney Disease market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Drugs to Treat Chronic Kidney Disease companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Drugs to Treat Chronic Kidney Disease Market Report

Report Metric	Details
Report Name	Drugs to Treat Chronic Kidney Disease Market
Segment by Type	Calcimimetics Vitamin D Sterols Potassium Binders Calcium-Based Phosphate Binders
Segment by Application	Hospital Pharmacies Online Pharmacies Retail Pharmacies
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer Inc., Johnson & Johnson, AbbVie Inc., Bayer AG, Novartis AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca plc, Eli Lilly and Company, C.H. Boehringer Sohn AG & Co. KG, Amgen Inc., Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Takeda Pharmaceutical Company Limited
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drugs to Treat Chronic Kidney Disease companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Drugs to Treat Chronic Kidney Disease Market report?

Ans: The main players in the Drugs to Treat Chronic Kidney Disease Market are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Bayer AG, Novartis AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca plc, Eli Lilly and Company, C.H. Boehringer Sohn AG & Co. KG, Amgen Inc., Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Takeda Pharmaceutical Company Limited

What are the Application segmentation covered in the Drugs to Treat Chronic Kidney Disease Market report?

Ans: The Applications covered in the Drugs to Treat Chronic Kidney Disease Market report are Hospital Pharmacies, Online Pharmacies, Retail Pharmacies

What are the Type segmentation covered in the Drugs to Treat Chronic Kidney Disease Market report?

Ans: The Types covered in the Drugs to Treat Chronic Kidney Disease Market report are Calcimimetics, Vitamin D, Sterols, Potassium Binders, Calcium-Based Phosphate Binders

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Drugs to Treat Chronic Kidney Disease Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Calcimimetics

1.2.3 Vitamin D

1.2.4 Sterols

1.2.5 Potassium Binders

1.2.6 Calcium-Based Phosphate Binders

1.3 Market by Application

1.3.1 Global Drugs to Treat Chronic Kidney Disease Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospital Pharmacies

1.3.3 Online Pharmacies

1.3.4 Retail Pharmacies

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Drugs to Treat Chronic Kidney Disease Market Perspective (2019-2030)

2.2 Drugs to Treat Chronic Kidney Disease Growth Trends by Region

2.2.1 Global Drugs to Treat Chronic Kidney Disease Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Drugs to Treat Chronic Kidney Disease Historic Market Size by Region (2019-2024)

2.2.3 Drugs to Treat Chronic Kidney Disease Forecasted Market Size by Region (2025-2030)

2.3 Drugs to Treat Chronic Kidney Disease Market Dynamics

2.3.1 Drugs to Treat Chronic Kidney Disease Industry Trends

2.3.2 Drugs to Treat Chronic Kidney Disease Market Drivers

2.3.3 Drugs to Treat Chronic Kidney Disease Market Challenges

2.3.4 Drugs to Treat Chronic Kidney Disease Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Drugs to Treat Chronic Kidney Disease Players by Revenue

3.1.1 Global Top Drugs to Treat Chronic Kidney Disease Players by Revenue (2019-2024)

3.1.2 Global Drugs to Treat Chronic Kidney Disease Revenue Market Share by Players (2019-2024)

3.2 Global Drugs to Treat Chronic Kidney Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Drugs to Treat Chronic Kidney Disease Revenue

3.4 Global Drugs to Treat Chronic Kidney Disease Market Concentration Ratio

3.4.1 Global Drugs to Treat Chronic Kidney Disease Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Drugs to Treat Chronic Kidney Disease Revenue in 2023

3.5 Drugs to Treat Chronic Kidney Disease Key Players Head office and Area Served

3.6 Key Players Drugs to Treat Chronic Kidney Disease Product Solution and Service

3.7 Date of Enter into Drugs to Treat Chronic Kidney Disease Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Drugs to Treat Chronic Kidney Disease Breakdown Data by Type

4.1 Global Drugs to Treat Chronic Kidney Disease Historic Market Size by Type (2019-2024)

4.2 Global Drugs to Treat Chronic Kidney Disease Forecasted Market Size by Type (2025-2030)

5 Drugs to Treat Chronic Kidney Disease Breakdown Data by Application

5.1 Global Drugs to Treat Chronic Kidney Disease Historic Market Size by Application (2019-2024)

5.2 Global Drugs to Treat Chronic Kidney Disease Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Drugs to Treat Chronic Kidney Disease Market Size (2019-2030)

6.2 North America Drugs to Treat Chronic Kidney Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Drugs to Treat Chronic Kidney Disease Market Size by Country (2019-2024)

6.4 North America Drugs to Treat Chronic Kidney Disease Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Drugs to Treat Chronic Kidney Disease Market Size (2019-2030)

7.2 Europe Drugs to Treat Chronic Kidney Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Drugs to Treat Chronic Kidney Disease Market Size by Country (2019-2024)

7.4 Europe Drugs to Treat Chronic Kidney Disease Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Drugs to Treat Chronic Kidney Disease Market Size (2019-2030)

8.2 Asia-Pacific Drugs to Treat Chronic Kidney Disease Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Drugs to Treat Chronic Kidney Disease Market Size by Region (2019-2024)

8.4 Asia-Pacific Drugs to Treat Chronic Kidney Disease Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Drugs to Treat Chronic Kidney Disease Market Size (2019-2030)

9.2 Latin America Drugs to Treat Chronic Kidney Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Drugs to Treat Chronic Kidney Disease Market Size by Country (2019-2024)

9.4 Latin America Drugs to Treat Chronic Kidney Disease Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Drugs to Treat Chronic Kidney Disease Market Size (2019-2030)

10.2 Middle East & Africa Drugs to Treat Chronic Kidney Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Drugs to Treat Chronic Kidney Disease Market Size by Country (2019-2024)

10.4 Middle East & Africa Drugs to Treat Chronic Kidney Disease Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pfizer Inc.

11.1.1 Pfizer Inc. Company Detail

11.1.2 Pfizer Inc. Business Overview

11.1.3 Pfizer Inc. Drugs to Treat Chronic Kidney Disease Introduction

11.1.4 Pfizer Inc. Revenue in Drugs to Treat Chronic Kidney Disease Business (2019-2024)

11.1.5 Pfizer Inc. Recent Development

11.2 Johnson & Johnson

11.2.1 Johnson & Johnson Company Detail

11.2.2 Johnson & Johnson Business Overview

11.2.3 Johnson & Johnson Drugs to Treat Chronic Kidney Disease Introduction

11.2.4 Johnson & Johnson Revenue in Drugs to Treat Chronic Kidney Disease Business (2019-2024)

11.2.5 Johnson & Johnson Recent Development

11.3 AbbVie Inc.

11.3.1 AbbVie Inc. Company Detail

11.3.2 AbbVie Inc. Business Overview

11.3.3 AbbVie Inc. Drugs to Treat Chronic Kidney Disease Introduction

11.3.4 AbbVie Inc. Revenue in Drugs to Treat Chronic Kidney Disease Business (2019-2024)

11.3.5 AbbVie Inc. Recent Development

11.4 Bayer AG

11.4.1 Bayer AG Company Detail

11.4.2 Bayer AG Business Overview

11.4.3 Bayer AG Drugs to Treat Chronic Kidney Disease Introduction

11.4.4 Bayer AG Revenue in Drugs to Treat Chronic Kidney Disease Business (2019-2024)

11.4.5 Bayer AG Recent Development

11.5 Novartis AG

11.5.1 Novartis AG Company Detail

11.5.2 Novartis AG Business Overview

11.5.3 Novartis AG Drugs to Treat Chronic Kidney Disease Introduction

11.5.4 Novartis AG Revenue in Drugs to Treat Chronic Kidney Disease Business (2019-2024)

11.5.5 Novartis AG Recent Development

11.6 Sanofi SA

11.6.1 Sanofi SA Company Detail

11.6.2 Sanofi SA Business Overview

11.6.3 Sanofi SA Drugs to Treat Chronic Kidney Disease Introduction

11.6.4 Sanofi SA Revenue in Drugs to Treat Chronic Kidney Disease Business (2019-2024)

11.6.5 Sanofi SA Recent Development

11.7 Bristol-Myers Squibb Company

11.7.1 Bristol-Myers Squibb Company Company Detail

11.7.2 Bristol-Myers Squibb Company Business Overview

11.7.3 Bristol-Myers Squibb Company Drugs to Treat Chronic Kidney Disease Introduction

11.7.4 Bristol-Myers Squibb Company Revenue in Drugs to Treat Chronic Kidney Disease Business (2019-2024)

11.7.5 Bristol-Myers Squibb Company Recent Development

11.8 AstraZeneca plc

11.8.1 AstraZeneca plc Company Detail

11.8.2 AstraZeneca plc Business Overview

11.8.3 AstraZeneca plc Drugs to Treat Chronic Kidney Disease Introduction

11.8.4 AstraZeneca plc Revenue in Drugs to Treat Chronic Kidney Disease Business (2019-2024)

11.8.5 AstraZeneca plc Recent Development

11.9 Eli Lilly and Company

11.9.1 Eli Lilly and Company Company Detail

11.9.2 Eli Lilly and Company Business Overview

11.9.3 Eli Lilly and Company Drugs to Treat Chronic Kidney Disease Introduction

11.9.4 Eli Lilly and Company Revenue in Drugs to Treat Chronic Kidney Disease Business (2019-2024)

11.9.5 Eli Lilly and Company Recent Development

11.10 C.H. Boehringer Sohn AG & Co. KG

11.10.1 C.H. Boehringer Sohn AG & Co. KG Company Detail

11.10.2 C.H. Boehringer Sohn AG & Co. KG Business Overview

11.10.3 C.H. Boehringer Sohn AG & Co. KG Drugs to Treat Chronic Kidney Disease Introduction

11.10.4 C.H. Boehringer Sohn AG & Co. KG Revenue in Drugs to Treat Chronic Kidney Disease Business (2019-2024)

11.10.5 C.H. Boehringer Sohn AG & Co. KG Recent Development

11.11 Amgen Inc.

11.11.1 Amgen Inc. Company Detail

11.11.2 Amgen Inc. Business Overview

11.11.3 Amgen Inc. Drugs to Treat Chronic Kidney Disease Introduction

11.11.4 Amgen Inc. Revenue in Drugs to Treat Chronic Kidney Disease Business (2019-2024)

11.11.5 Amgen Inc. Recent Development

11.12 Novo Nordisk A/S

11.12.1 Novo Nordisk A/S Company Detail

11.12.2 Novo Nordisk A/S Business Overview

11.12.3 Novo Nordisk A/S Drugs to Treat Chronic Kidney Disease Introduction

11.12.4 Novo Nordisk A/S Revenue in Drugs to Treat Chronic Kidney Disease Business (2019-2024)

11.12.5 Novo Nordisk A/S Recent Development

11.13 Teva Pharmaceutical Industries Ltd.

11.13.1 Teva Pharmaceutical Industries Ltd. Company Detail

11.13.2 Teva Pharmaceutical Industries Ltd. Business Overview

11.13.3 Teva Pharmaceutical Industries Ltd. Drugs to Treat Chronic Kidney Disease Introduction

11.13.4 Teva Pharmaceutical Industries Ltd. Revenue in Drugs to Treat Chronic Kidney Disease Business (2019-2024)

11.13.5 Teva Pharmaceutical Industries Ltd. Recent Development

11.14 Otsuka Pharmaceutical Co. Ltd.

11.14.1 Otsuka Pharmaceutical Co. Ltd. Company Detail

11.14.2 Otsuka Pharmaceutical Co. Ltd. Business Overview

11.14.3 Otsuka Pharmaceutical Co. Ltd. Drugs to Treat Chronic Kidney Disease Introduction

11.14.4 Otsuka Pharmaceutical Co. Ltd. Revenue in Drugs to Treat Chronic Kidney Disease Business (2019-2024)

11.14.5 Otsuka Pharmaceutical Co. Ltd. Recent Development

11.15 Takeda Pharmaceutical Company Limited

11.15.1 Takeda Pharmaceutical Company Limited Company Detail

11.15.2 Takeda Pharmaceutical Company Limited Business Overview

11.15.3 Takeda Pharmaceutical Company Limited Drugs to Treat Chronic Kidney Disease Introduction

11.15.4 Takeda Pharmaceutical Company Limited Revenue in Drugs to Treat Chronic Kidney Disease Business (2019-2024)

11.15.5 Takeda Pharmaceutical Company Limited Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Bristol Myers Squibb Company

Astrazeneca plc

C. H. Boehringer Sohn AG & Co. KG

Amgen Inc

Novo Nordisk A S

Teva Pharmaceutical Industries Ltd

Otsuka Pharmaceutical Co Ltd

Takeda Pharmaceutical Company Limited

List of Tables

Table 1. Global Drugs to Treat Chronic Kidney Disease Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Calcimimetics

Table 3. Key Players of Vitamin D

Table 4. Key Players of Sterols

Table 5. Key Players of Potassium Binders

Table 6. Key Players of Calcium-Based Phosphate Binders

Table 7. Global Drugs to Treat Chronic Kidney Disease Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Drugs to Treat Chronic Kidney Disease Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Drugs to Treat Chronic Kidney Disease Market Size by Region (2019-2024) & (US$ Million)

Table 10. Global Drugs to Treat Chronic Kidney Disease Market Share by Region (2019-2024)

Table 11. Global Drugs to Treat Chronic Kidney Disease Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 12. Global Drugs to Treat Chronic Kidney Disease Market Share by Region (2025-2030)

Table 13. Drugs to Treat Chronic Kidney Disease Market Trends

Table 14. Drugs to Treat Chronic Kidney Disease Market Drivers

Table 15. Drugs to Treat Chronic Kidney Disease Market Challenges

Table 16. Drugs to Treat Chronic Kidney Disease Market Restraints

Table 17. Global Drugs to Treat Chronic Kidney Disease Revenue by Players (2019-2024) & (US$ Million)

Table 18. Global Drugs to Treat Chronic Kidney Disease Market Share by Players (2019-2024)

Table 19. Global Top Drugs to Treat Chronic Kidney Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs to Treat Chronic Kidney Disease as of 2023)

Table 20. Ranking of Global Top Drugs to Treat Chronic Kidney Disease Companies by Revenue (US$ Million) in 2023

Table 21. Global 5 Largest Players Market Share by Drugs to Treat Chronic Kidney Disease Revenue (CR5 and HHI) & (2019-2024)

Table 22. Key Players Headquarters and Area Served

Table 23. Key Players Drugs to Treat Chronic Kidney Disease Product Solution and Service

Table 24. Date of Enter into Drugs to Treat Chronic Kidney Disease Market

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Drugs to Treat Chronic Kidney Disease Market Size by Type (2019-2024) & (US$ Million)

Table 27. Global Drugs to Treat Chronic Kidney Disease Revenue Market Share by Type (2019-2024)

Table 28. Global Drugs to Treat Chronic Kidney Disease Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 29. Global Drugs to Treat Chronic Kidney Disease Revenue Market Share by Type (2025-2030)

Table 30. Global Drugs to Treat Chronic Kidney Disease Market Size by Application (2019-2024) & (US$ Million)

Table 31. Global Drugs to Treat Chronic Kidney Disease Revenue Market Share by Application (2019-2024)

Table 32. Global Drugs to Treat Chronic Kidney Disease Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 33. Global Drugs to Treat Chronic Kidney Disease Revenue Market Share by Application (2025-2030)

Table 34. North America Drugs to Treat Chronic Kidney Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. North America Drugs to Treat Chronic Kidney Disease Market Size by Country (2019-2024) & (US$ Million)

Table 36. North America Drugs to Treat Chronic Kidney Disease Market Size by Country (2025-2030) & (US$ Million)

Table 37. Europe Drugs to Treat Chronic Kidney Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. Europe Drugs to Treat Chronic Kidney Disease Market Size by Country (2019-2024) & (US$ Million)

Table 39. Europe Drugs to Treat Chronic Kidney Disease Market Size by Country (2025-2030) & (US$ Million)

Table 40. Asia-Pacific Drugs to Treat Chronic Kidney Disease Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 41. Asia-Pacific Drugs to Treat Chronic Kidney Disease Market Size by Region (2019-2024) & (US$ Million)

Table 42. Asia-Pacific Drugs to Treat Chronic Kidney Disease Market Size by Region (2025-2030) & (US$ Million)

Table 43. Latin America Drugs to Treat Chronic Kidney Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Latin America Drugs to Treat Chronic Kidney Disease Market Size by Country (2019-2024) & (US$ Million)

Table 45. Latin America Drugs to Treat Chronic Kidney Disease Market Size by Country (2025-2030) & (US$ Million)

Table 46. Middle East & Africa Drugs to Treat Chronic Kidney Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 47. Middle East & Africa Drugs to Treat Chronic Kidney Disease Market Size by Country (2019-2024) & (US$ Million)

Table 48. Middle East & Africa Drugs to Treat Chronic Kidney Disease Market Size by Country (2025-2030) & (US$ Million)

Table 49. Pfizer Inc. Company Detail

Table 50. Pfizer Inc. Business Overview

Table 51. Pfizer Inc. Drugs to Treat Chronic Kidney Disease Product

Table 52. Pfizer Inc. Revenue in Drugs to Treat Chronic Kidney Disease Business (2019-2024) & (US$ Million)

Table 53. Pfizer Inc. Recent Development

Table 54. Johnson & Johnson Company Detail

Table 55. Johnson & Johnson Business Overview

Table 56. Johnson & Johnson Drugs to Treat Chronic Kidney Disease Product

Table 57. Johnson & Johnson Revenue in Drugs to Treat Chronic Kidney Disease Business (2019-2024) & (US$ Million)

Table 58. Johnson & Johnson Recent Development

Table 59. AbbVie Inc. Company Detail

Table 60. AbbVie Inc. Business Overview

Table 61. AbbVie Inc. Drugs to Treat Chronic Kidney Disease Product

Table 62. AbbVie Inc. Revenue in Drugs to Treat Chronic Kidney Disease Business (2019-2024) & (US$ Million)

Table 63. AbbVie Inc. Recent Development

Table 64. Bayer AG Company Detail

Table 65. Bayer AG Business Overview

Table 66. Bayer AG Drugs to Treat Chronic Kidney Disease Product

Table 67. Bayer AG Revenue in Drugs to Treat Chronic Kidney Disease Business (2019-2024) & (US$ Million)

Table 68. Bayer AG Recent Development

Table 69. Novartis AG Company Detail

Table 70. Novartis AG Business Overview

Table 71. Novartis AG Drugs to Treat Chronic Kidney Disease Product

Table 72. Novartis AG Revenue in Drugs to Treat Chronic Kidney Disease Business (2019-2024) & (US$ Million)

Table 73. Novartis AG Recent Development

Table 74. Sanofi SA Company Detail

Table 75. Sanofi SA Business Overview

Table 76. Sanofi SA Drugs to Treat Chronic Kidney Disease Product

Table 77. Sanofi SA Revenue in Drugs to Treat Chronic Kidney Disease Business (2019-2024) & (US$ Million)

Table 78. Sanofi SA Recent Development

Table 79. Bristol-Myers Squibb Company Company Detail

Table 80. Bristol-Myers Squibb Company Business Overview

Table 81. Bristol-Myers Squibb Company Drugs to Treat Chronic Kidney Disease Product

Table 82. Bristol-Myers Squibb Company Revenue in Drugs to Treat Chronic Kidney Disease Business (2019-2024) & (US$ Million)

Table 83. Bristol-Myers Squibb Company Recent Development

Table 84. AstraZeneca plc Company Detail

Table 85. AstraZeneca plc Business Overview

Table 86. AstraZeneca plc Drugs to Treat Chronic Kidney Disease Product

Table 87. AstraZeneca plc Revenue in Drugs to Treat Chronic Kidney Disease Business (2019-2024) & (US$ Million)

Table 88. AstraZeneca plc Recent Development

Table 89. Eli Lilly and Company Company Detail

Table 90. Eli Lilly and Company Business Overview

Table 91. Eli Lilly and Company Drugs to Treat Chronic Kidney Disease Product

Table 92. Eli Lilly and Company Revenue in Drugs to Treat Chronic Kidney Disease Business (2019-2024) & (US$ Million)

Table 93. Eli Lilly and Company Recent Development

Table 94. C.H. Boehringer Sohn AG & Co. KG Company Detail

Table 95. C.H. Boehringer Sohn AG & Co. KG Business Overview

Table 96. C.H. Boehringer Sohn AG & Co. KG Drugs to Treat Chronic Kidney Disease Product

Table 97. C.H. Boehringer Sohn AG & Co. KG Revenue in Drugs to Treat Chronic Kidney Disease Business (2019-2024) & (US$ Million)

Table 98. C.H. Boehringer Sohn AG & Co. KG Recent Development

Table 99. Amgen Inc. Company Detail

Table 100. Amgen Inc. Business Overview

Table 101. Amgen Inc. Drugs to Treat Chronic Kidney Disease Product

Table 102. Amgen Inc. Revenue in Drugs to Treat Chronic Kidney Disease Business (2019-2024) & (US$ Million)

Table 103. Amgen Inc. Recent Development

Table 104. Novo Nordisk A/S Company Detail

Table 105. Novo Nordisk A/S Business Overview

Table 106. Novo Nordisk A/S Drugs to Treat Chronic Kidney Disease Product

Table 107. Novo Nordisk A/S Revenue in Drugs to Treat Chronic Kidney Disease Business (2019-2024) & (US$ Million)

Table 108. Novo Nordisk A/S Recent Development

Table 109. Teva Pharmaceutical Industries Ltd. Company Detail

Table 110. Teva Pharmaceutical Industries Ltd. Business Overview

Table 111. Teva Pharmaceutical Industries Ltd. Drugs to Treat Chronic Kidney Disease Product

Table 112. Teva Pharmaceutical Industries Ltd. Revenue in Drugs to Treat Chronic Kidney Disease Business (2019-2024) & (US$ Million)

Table 113. Teva Pharmaceutical Industries Ltd. Recent Development

Table 114. Otsuka Pharmaceutical Co. Ltd. Company Detail

Table 115. Otsuka Pharmaceutical Co. Ltd. Business Overview

Table 116. Otsuka Pharmaceutical Co. Ltd. Drugs to Treat Chronic Kidney Disease Product

Table 117. Otsuka Pharmaceutical Co. Ltd. Revenue in Drugs to Treat Chronic Kidney Disease Business (2019-2024) & (US$ Million)

Table 118. Otsuka Pharmaceutical Co. Ltd. Recent Development

Table 119. Takeda Pharmaceutical Company Limited Company Detail

Table 120. Takeda Pharmaceutical Company Limited Business Overview

Table 121. Takeda Pharmaceutical Company Limited Drugs to Treat Chronic Kidney Disease Product

Table 122. Takeda Pharmaceutical Company Limited Revenue in Drugs to Treat Chronic Kidney Disease Business (2019-2024) & (US$ Million)

Table 123. Takeda Pharmaceutical Company Limited Recent Development

Table 124. Research Programs/Design for This Report

Table 125. Key Data Information from Secondary Sources

Table 126. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Drugs to Treat Chronic Kidney Disease Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Drugs to Treat Chronic Kidney Disease Market Share by Type: 2023 VS 2030

Figure 3. Calcimimetics Features

Figure 4. Vitamin D Features

Figure 5. Sterols Features

Figure 6. Potassium Binders Features

Figure 7. Calcium-Based Phosphate Binders Features

Figure 8. Global Drugs to Treat Chronic Kidney Disease Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 9. Global Drugs to Treat Chronic Kidney Disease Market Share by Application: 2023 VS 2030

Figure 10. Hospital Pharmacies Case Studies

Figure 11. Online Pharmacies Case Studies

Figure 12. Retail Pharmacies Case Studies

Figure 13. Drugs to Treat Chronic Kidney Disease Report Years Considered

Figure 14. Global Drugs to Treat Chronic Kidney Disease Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 15. Global Drugs to Treat Chronic Kidney Disease Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Drugs to Treat Chronic Kidney Disease Market Share by Region: 2023 VS 2030

Figure 17. Global Drugs to Treat Chronic Kidney Disease Market Share by Players in 2023

Figure 18. Global Top Drugs to Treat Chronic Kidney Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs to Treat Chronic Kidney Disease as of 2023)

Figure 19. The Top 10 and 5 Players Market Share by Drugs to Treat Chronic Kidney Disease Revenue in 2023

Figure 20. North America Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. North America Drugs to Treat Chronic Kidney Disease Market Share by Country (2019-2030)

Figure 22. United States Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Drugs to Treat Chronic Kidney Disease Market Share by Country (2019-2030)

Figure 26. Germany Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. France Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. U.K. Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Italy Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Russia Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Nordic Countries Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific Drugs to Treat Chronic Kidney Disease Market Share by Region (2019-2030)

Figure 34. China Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Japan Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. South Korea Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Southeast Asia Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. India Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Australia Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America Drugs to Treat Chronic Kidney Disease Market Share by Country (2019-2030)

Figure 42. Mexico Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Brazil Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Drugs to Treat Chronic Kidney Disease Market Share by Country (2019-2030)

Figure 46. Turkey Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Saudi Arabia Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Pfizer Inc. Revenue Growth Rate in Drugs to Treat Chronic Kidney Disease Business (2019-2024)

Figure 49. Johnson & Johnson Revenue Growth Rate in Drugs to Treat Chronic Kidney Disease Business (2019-2024)

Figure 50. AbbVie Inc. Revenue Growth Rate in Drugs to Treat Chronic Kidney Disease Business (2019-2024)

Figure 51. Bayer AG Revenue Growth Rate in Drugs to Treat Chronic Kidney Disease Business (2019-2024)

Figure 52. Novartis AG Revenue Growth Rate in Drugs to Treat Chronic Kidney Disease Business (2019-2024)

Figure 53. Sanofi SA Revenue Growth Rate in Drugs to Treat Chronic Kidney Disease Business (2019-2024)

Figure 54. Bristol-Myers Squibb Company Revenue Growth Rate in Drugs to Treat Chronic Kidney Disease Business (2019-2024)

Figure 55. AstraZeneca plc Revenue Growth Rate in Drugs to Treat Chronic Kidney Disease Business (2019-2024)

Figure 56. Eli Lilly and Company Revenue Growth Rate in Drugs to Treat Chronic Kidney Disease Business (2019-2024)

Figure 57. C.H. Boehringer Sohn AG & Co. KG Revenue Growth Rate in Drugs to Treat Chronic Kidney Disease Business (2019-2024)

Figure 58. Amgen Inc. Revenue Growth Rate in Drugs to Treat Chronic Kidney Disease Business (2019-2024)

Figure 59. Novo Nordisk A/S Revenue Growth Rate in Drugs to Treat Chronic Kidney Disease Business (2019-2024)

Figure 60. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Drugs to Treat Chronic Kidney Disease Business (2019-2024)

Figure 61. Otsuka Pharmaceutical Co. Ltd. Revenue Growth Rate in Drugs to Treat Chronic Kidney Disease Business (2019-2024)

Figure 62. Takeda Pharmaceutical Company Limited Revenue Growth Rate in Drugs to Treat Chronic Kidney Disease Business (2019-2024)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Chronic Kidney Disease CKD Treatment Market Research Report 2025

Renal Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Late Stage Chronic Kidney Disease Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Chronic Kidney Disease Drugs Market Research Report 2025

Kidney Disease Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Renal Disease Treatment Market Research Report 2024

Global Kidney Medicine Market Insights Forecast to 2030

Chronic Kidney Disease CKD Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

End Stage Renal Disease Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Kidney Fibrosis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Kidney Fibrosis Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Chronic Kidney Disease Nutritional Supplement Market Research Report 2024

Global Chronic Disease Treatment Market Research Report 2024

Global Complement Drug for Kidney Disease Market Research Report 2024

Global Renal Therapeutic Market Research Report 2025

Kidney Renal Fibrosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Renal Medical Devices Market Research Report 2024

Rare Kidney Diseases Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Polycystic Kidney Disease Treatment Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

[email protected]

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

	
		OSZAR »